On June 30, 2026, Anthropic revealed its plans to launch an AI-driven drug discovery program, expanding its operations into the healthcare sector.
This initiative aims to utilize artificial intelligence to enhance the drug discovery process, a move that reflects a growing trend among technology companies investing in healthcare solutions.
The introduction of this program may potentially speed up the development of new pharmaceuticals, although the specifics of its implementation remain to be seen.